We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The University of Saskatchewan (USask) in Canada has reported positive data from preclinical studies of the Covid-19 vaccine candidate developed by its Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).